Thirdly, our proof-of-concept studies were limited to examining one CF-causing mutation, F508del, and our study involved an insufficient number of individuals to address whether different CFTR mutations affect poliovirus nAB responses. This evidence concerns the gene CFTR and cystic fibrosis.